- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x ACT: ACETATE ION(Non-functional Binders)
- 18 x GLV: GLYOXYLIC ACID(Non-covalent)
GLV.2: 8 residues within 4Å:- Chain A: D.52, R.84, E.158, G.189, V.191, D.192, W.257
- Ligands: PB.6
Ligand excluded by PLIPGLV.3: 6 residues within 4Å:- Chain A: R.89, D.90, E.161, D.196
- Ligands: PB.5, PB.7
Ligand excluded by PLIPGLV.4: 6 residues within 4Å:- Chain A: E.51, D.52, H.88, E.123, D.192
- Ligands: PB.6
Ligand excluded by PLIPGLV.18: 8 residues within 4Å:- Chain B: D.52, R.84, E.158, G.189, V.191, D.192, W.257
- Ligands: PB.22
Ligand excluded by PLIPGLV.19: 6 residues within 4Å:- Chain B: R.89, D.90, E.161, D.196
- Ligands: PB.21, PB.23
Ligand excluded by PLIPGLV.20: 6 residues within 4Å:- Chain B: E.51, D.52, H.88, E.123, D.192
- Ligands: PB.22
Ligand excluded by PLIPGLV.34: 8 residues within 4Å:- Chain C: D.52, R.84, E.158, G.189, V.191, D.192, W.257
- Ligands: PB.38
Ligand excluded by PLIPGLV.35: 6 residues within 4Å:- Chain C: R.89, D.90, E.161, D.196
- Ligands: PB.37, PB.39
Ligand excluded by PLIPGLV.36: 6 residues within 4Å:- Chain C: E.51, D.52, H.88, E.123, D.192
- Ligands: PB.38
Ligand excluded by PLIPGLV.50: 8 residues within 4Å:- Chain D: D.52, R.84, E.158, G.189, V.191, D.192, W.257
- Ligands: PB.54
Ligand excluded by PLIPGLV.51: 6 residues within 4Å:- Chain D: R.89, D.90, E.161, D.196
- Ligands: PB.53, PB.55
Ligand excluded by PLIPGLV.52: 6 residues within 4Å:- Chain D: E.51, D.52, H.88, E.123, D.192
- Ligands: PB.54
Ligand excluded by PLIPGLV.66: 8 residues within 4Å:- Chain E: D.52, R.84, E.158, G.189, V.191, D.192, W.257
- Ligands: PB.70
Ligand excluded by PLIPGLV.67: 6 residues within 4Å:- Chain E: R.89, D.90, E.161, D.196
- Ligands: PB.69, PB.71
Ligand excluded by PLIPGLV.68: 6 residues within 4Å:- Chain E: E.51, D.52, H.88, E.123, D.192
- Ligands: PB.70
Ligand excluded by PLIPGLV.82: 8 residues within 4Å:- Chain F: D.52, R.84, E.158, G.189, V.191, D.192, W.257
- Ligands: PB.86
Ligand excluded by PLIPGLV.83: 6 residues within 4Å:- Chain F: R.89, D.90, E.161, D.196
- Ligands: PB.85, PB.87
Ligand excluded by PLIPGLV.84: 6 residues within 4Å:- Chain F: E.51, D.52, H.88, E.123, D.192
- Ligands: PB.86
Ligand excluded by PLIP- 24 x PB: LEAD (II) ION(Non-covalent)
PB.5: 4 residues within 4Å:- Chain A: E.161, D.196
- Chain C: S.221
- Ligands: GLV.3
Ligand excluded by PLIPPB.6: 7 residues within 4Å:- Chain A: E.51, D.52, E.123, E.158, D.192
- Ligands: GLV.2, GLV.4
Ligand excluded by PLIPPB.7: 3 residues within 4Å:- Chain A: D.90, E.161
- Ligands: GLV.3
Ligand excluded by PLIPPB.8: 3 residues within 4Å:- Chain A: D.344, D.348, R.427
Ligand excluded by PLIPPB.21: 4 residues within 4Å:- Chain A: S.221
- Chain B: E.161, D.196
- Ligands: GLV.19
Ligand excluded by PLIPPB.22: 7 residues within 4Å:- Chain B: E.51, D.52, E.123, E.158, D.192
- Ligands: GLV.18, GLV.20
Ligand excluded by PLIPPB.23: 3 residues within 4Å:- Chain B: D.90, E.161
- Ligands: GLV.19
Ligand excluded by PLIPPB.24: 3 residues within 4Å:- Chain B: D.344, D.348, R.427
Ligand excluded by PLIPPB.37: 4 residues within 4Å:- Chain B: S.221
- Chain C: E.161, D.196
- Ligands: GLV.35
Ligand excluded by PLIPPB.38: 7 residues within 4Å:- Chain C: E.51, D.52, E.123, E.158, D.192
- Ligands: GLV.34, GLV.36
Ligand excluded by PLIPPB.39: 3 residues within 4Å:- Chain C: D.90, E.161
- Ligands: GLV.35
Ligand excluded by PLIPPB.40: 3 residues within 4Å:- Chain C: D.344, D.348, R.427
Ligand excluded by PLIPPB.53: 4 residues within 4Å:- Chain D: E.161, D.196
- Chain F: S.221
- Ligands: GLV.51
Ligand excluded by PLIPPB.54: 7 residues within 4Å:- Chain D: E.51, D.52, E.123, E.158, D.192
- Ligands: GLV.50, GLV.52
Ligand excluded by PLIPPB.55: 3 residues within 4Å:- Chain D: D.90, E.161
- Ligands: GLV.51
Ligand excluded by PLIPPB.56: 3 residues within 4Å:- Chain D: D.344, D.348, R.427
Ligand excluded by PLIPPB.69: 4 residues within 4Å:- Chain D: S.221
- Chain E: E.161, D.196
- Ligands: GLV.67
Ligand excluded by PLIPPB.70: 7 residues within 4Å:- Chain E: E.51, D.52, E.123, E.158, D.192
- Ligands: GLV.66, GLV.68
Ligand excluded by PLIPPB.71: 3 residues within 4Å:- Chain E: D.90, E.161
- Ligands: GLV.67
Ligand excluded by PLIPPB.72: 3 residues within 4Å:- Chain E: D.344, D.348, R.427
Ligand excluded by PLIPPB.85: 4 residues within 4Å:- Chain E: S.221
- Chain F: E.161, D.196
- Ligands: GLV.83
Ligand excluded by PLIPPB.86: 7 residues within 4Å:- Chain F: E.51, D.52, E.123, E.158, D.192
- Ligands: GLV.82, GLV.84
Ligand excluded by PLIPPB.87: 3 residues within 4Å:- Chain F: D.90, E.161
- Ligands: GLV.83
Ligand excluded by PLIPPB.88: 3 residues within 4Å:- Chain F: D.344, D.348, R.427
Ligand excluded by PLIP- 18 x K: POTASSIUM ION(Non-covalent)
K.9: 6 residues within 4Å:- Chain A: M.173, G.174, K.175, N.178, E.181
- Ligands: ACT.1
Ligand excluded by PLIPK.10: 5 residues within 4Å:- Chain A: S.217, S.221, G.252
- Chain B: M.197
- Ligands: CL.14
Ligand excluded by PLIPK.11: 4 residues within 4Å:- Chain A: P.176, N.178, N.179
- Ligands: ACT.1
Ligand excluded by PLIPK.25: 6 residues within 4Å:- Chain B: M.173, G.174, K.175, N.178, E.181
- Ligands: ACT.17
Ligand excluded by PLIPK.26: 5 residues within 4Å:- Chain B: S.217, S.221, G.252
- Chain C: M.197
- Ligands: CL.30
Ligand excluded by PLIPK.27: 4 residues within 4Å:- Chain B: P.176, N.178, N.179
- Ligands: ACT.17
Ligand excluded by PLIPK.41: 6 residues within 4Å:- Chain C: M.173, G.174, K.175, N.178, E.181
- Ligands: ACT.33
Ligand excluded by PLIPK.42: 5 residues within 4Å:- Chain A: M.197
- Chain C: S.217, S.221, G.252
- Ligands: CL.46
Ligand excluded by PLIPK.43: 4 residues within 4Å:- Chain C: P.176, N.178, N.179
- Ligands: ACT.33
Ligand excluded by PLIPK.57: 6 residues within 4Å:- Chain D: M.173, G.174, K.175, N.178, E.181
- Ligands: ACT.49
Ligand excluded by PLIPK.58: 5 residues within 4Å:- Chain D: S.217, S.221, G.252
- Chain E: M.197
- Ligands: CL.62
Ligand excluded by PLIPK.59: 4 residues within 4Å:- Chain D: P.176, N.178, N.179
- Ligands: ACT.49
Ligand excluded by PLIPK.73: 6 residues within 4Å:- Chain E: M.173, G.174, K.175, N.178, E.181
- Ligands: ACT.65
Ligand excluded by PLIPK.74: 5 residues within 4Å:- Chain E: S.217, S.221, G.252
- Chain F: M.197
- Ligands: CL.78
Ligand excluded by PLIPK.75: 4 residues within 4Å:- Chain E: P.176, N.178, N.179
- Ligands: ACT.65
Ligand excluded by PLIPK.89: 6 residues within 4Å:- Chain F: M.173, G.174, K.175, N.178, E.181
- Ligands: ACT.81
Ligand excluded by PLIPK.90: 5 residues within 4Å:- Chain D: M.197
- Chain F: S.217, S.221, G.252
- Ligands: CL.94
Ligand excluded by PLIPK.91: 4 residues within 4Å:- Chain F: P.176, N.178, N.179
- Ligands: ACT.81
Ligand excluded by PLIP- 24 x CL: CHLORIDE ION(Non-functional Binders)
CL.12: 4 residues within 4Å:- Chain A: R.89, D.90, P.92, R.95
Ligand excluded by PLIPCL.13: 5 residues within 4Å:- Chain A: R.218
- Chain B: R.218
- Chain C: R.218
- Ligands: CL.29, CL.45
Ligand excluded by PLIPCL.14: 5 residues within 4Å:- Chain A: V.226, A.227, G.252
- Chain B: R.198
- Ligands: K.10
Ligand excluded by PLIPCL.15: 4 residues within 4Å:- Chain A: G.125, G.126
- Chain C: R.170
- Chain E: T.177
Ligand excluded by PLIPCL.28: 4 residues within 4Å:- Chain B: R.89, D.90, P.92, R.95
Ligand excluded by PLIPCL.29: 5 residues within 4Å:- Chain A: R.218
- Chain B: R.218
- Chain C: R.218
- Ligands: CL.13, CL.45
Ligand excluded by PLIPCL.30: 5 residues within 4Å:- Chain B: V.226, A.227, G.252
- Chain C: R.198
- Ligands: K.26
Ligand excluded by PLIPCL.31: 4 residues within 4Å:- Chain A: R.170
- Chain B: G.125, G.126
- Chain D: T.177
Ligand excluded by PLIPCL.44: 4 residues within 4Å:- Chain C: R.89, D.90, P.92, R.95
Ligand excluded by PLIPCL.45: 5 residues within 4Å:- Chain A: R.218
- Chain B: R.218
- Chain C: R.218
- Ligands: CL.13, CL.29
Ligand excluded by PLIPCL.46: 5 residues within 4Å:- Chain A: R.198
- Chain C: V.226, A.227, G.252
- Ligands: K.42
Ligand excluded by PLIPCL.47: 4 residues within 4Å:- Chain B: R.170
- Chain C: G.125, G.126
- Chain F: T.177
Ligand excluded by PLIPCL.60: 4 residues within 4Å:- Chain D: R.89, D.90, P.92, R.95
Ligand excluded by PLIPCL.61: 5 residues within 4Å:- Chain D: R.218
- Chain E: R.218
- Chain F: R.218
- Ligands: CL.77, CL.93
Ligand excluded by PLIPCL.62: 5 residues within 4Å:- Chain D: V.226, A.227, G.252
- Chain E: R.198
- Ligands: K.58
Ligand excluded by PLIPCL.63: 4 residues within 4Å:- Chain B: T.177
- Chain D: G.125, G.126
- Chain F: R.170
Ligand excluded by PLIPCL.76: 4 residues within 4Å:- Chain E: R.89, D.90, P.92, R.95
Ligand excluded by PLIPCL.77: 5 residues within 4Å:- Chain D: R.218
- Chain E: R.218
- Chain F: R.218
- Ligands: CL.61, CL.93
Ligand excluded by PLIPCL.78: 5 residues within 4Å:- Chain E: V.226, A.227, G.252
- Chain F: R.198
- Ligands: K.74
Ligand excluded by PLIPCL.79: 4 residues within 4Å:- Chain A: T.177
- Chain D: R.170
- Chain E: G.125, G.126
Ligand excluded by PLIPCL.92: 4 residues within 4Å:- Chain F: R.89, D.90, P.92, R.95
Ligand excluded by PLIPCL.93: 5 residues within 4Å:- Chain D: R.218
- Chain E: R.218
- Chain F: R.218
- Ligands: CL.61, CL.77
Ligand excluded by PLIPCL.94: 5 residues within 4Å:- Chain D: R.198
- Chain F: V.226, A.227, G.252
- Ligands: K.90
Ligand excluded by PLIPCL.95: 4 residues within 4Å:- Chain C: T.177
- Chain E: R.170
- Chain F: G.125, G.126
Ligand excluded by PLIP- 6 x NA: SODIUM ION(Non-functional Binders)
NA.16: 2 residues within 4Å:- Chain A: N.408
- Chain C: P.78
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:P.78
NA.32: 2 residues within 4Å:- Chain A: P.78
- Chain B: N.408
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:P.78
NA.48: 2 residues within 4Å:- Chain B: P.78
- Chain C: N.408
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.408
NA.64: 2 residues within 4Å:- Chain D: N.408
- Chain F: P.78
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:N.408
NA.80: 2 residues within 4Å:- Chain D: P.78
- Chain E: N.408
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:P.78
NA.96: 2 residues within 4Å:- Chain E: P.78
- Chain F: N.408
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:N.408
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Adams, M.J. et al., X-ray analysis of Lead(II) binding to Haloferax volcanii Malate Synthase. The Journal of the Utah Academy (2016)
- Release Date
- 2016-11-09
- Peptides
- Malate synthase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x ACT: ACETATE ION(Non-functional Binders)
- 18 x GLV: GLYOXYLIC ACID(Non-covalent)
- 24 x PB: LEAD (II) ION(Non-covalent)
- 18 x K: POTASSIUM ION(Non-covalent)
- 24 x CL: CHLORIDE ION(Non-functional Binders)
- 6 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Adams, M.J. et al., X-ray analysis of Lead(II) binding to Haloferax volcanii Malate Synthase. The Journal of the Utah Academy (2016)
- Release Date
- 2016-11-09
- Peptides
- Malate synthase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A